Literature DB >> 170411

Mapping RNase T1-resistant oligonucleotides of avian tumor virus RNAs: sarcoma-specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly(A) end.

L H Wang, P Duesberg, K Beemon, P K Vogt.   

Abstract

The large RNase T1-resistant oligonucleotides of the nondefective (nd) Rous sarcoma virus (RSV): Prague RSV of subgroup B (PR-B), PR-C and B77 of subgroup C; of their transformation-defective (td0 deletion mutants: td PR-B, td PR-C, and td B77; and of replication-defective (rd) RSV(-) were completely or partially mapped on the 30 to 40S viral RNAs. The location of a given oligonucleotide relative to the poly(A) terminus of the viral RNAs was directly deduced from the smallest size of the poly(A)-tagged RNA fragment from which it could be isolated. Identification of distinct oligonucleotides was based on their location in the electrophoretic/chromatographic fingerprint pattern and on analysis of their RNase A-resistant fragments. The following results were obtained. (i) The number of large oligonucleotides per poly(A)-tagged ffagment increased with increasing size of the fragment. This implies that the genetic map is linear and that a given RNase T1-resistant oligonucleotides has, relative to the poly(A) end, the same location on all 30 to 40S RNA subunits of a given 60 to 70S viral RNA complex, (ii) Three sarcoma-specific oligonucleotides were identified in the RNAs of Pr-B, PR-C and B77 by comparison with the RNAs of the corresponding td viruses...

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170411      PMCID: PMC354767     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Electron microscope measurements of rous sarcoma virus RNA.

Authors:  H Delius; P H Duesberg; W F Mangel
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Studies on the structure and synthesis of Rous sarcoma virus RNA.

Authors:  C Weissmann; J T Parsons; J W Coffin; L Rymo; M A Billeter; H Hofstetter
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Electron microscope studies of tumor virus RNA.

Authors:  H J Kung; J M Bailey; N Davidson; P K Vogt; M O Nicolson; R M McAllister
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  Avian RNA tumor viruses: mechanism of recombination and complexity of the genome.

Authors:  P Duesberg; P K Vogt; K Beemon; M Lai
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

5.  Host induced alteration of avian sarcoma virus B-77 genome.

Authors:  M Shoyab; P D Markham; M A Baluda
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

6.  Isolation of different kinds of non-virus producing chick cells transformed by Schmidt-Ruppin strain (subgroup A) of Rous sarcoma virus.

Authors:  S Kawai; T Yamamoto
Journal:  Jpn J Exp Med       Date:  1970-08

7.  Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses.

Authors:  P H Duesberg; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

8.  Characteristics of two new avian tumor virus subgroups.

Authors:  R G Duff; P K Vogt
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

9.  Tumor viruses: 1974.

Authors:  D Baltimore
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

10.  Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity.

Authors:  C Y Kang; H M Temin
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

View more
  108 in total

1.  Evidence for the identity of shared 5'-terminal sequences between genome RNA and subgenomic mRNA's of B77 avian sarcoma virus.

Authors:  C M Stoltzfus; L K Kuhnert
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  Effect of viral RNase H on the avian sarcoma viral genome during early transcription in vitro.

Authors:  R Friedrich; K Moelling
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

3.  Transformation-defective mutants of Rous sarcoma virus with longer sizes of genome RNA and their highly frequent occurrences.

Authors:  M Yoshida; M Yamashita; A Nomoto
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

4.  Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates.

Authors:  D H Spector; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

5.  Processing of 60,000-dalton sarc gene protein synthesized by cell-free translation.

Authors:  J Kamine; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

6.  Discovery of oncogenes: The advent of molecular cancer research.

Authors:  Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

7.  Mechanism of tumor cell killing by HO-221, a novel antitumor compound.

Authors:  T Nakajima; T Okamoto; H Masuda; M Watanabe; K Yokoyama; N Yamada; S Tsukagoshi; T Taguchi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Genomic complexities of murine leukemia and sarcoma, reticuloendotheliosis, and visna viruses.

Authors:  K L Beemon; A J Faras; A T Hasse; P H Duesberg; J E Maisel
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

9.  Deletion mapping of moloney type C virus: polypeptide and nucleic acid expression in different transforming virus isolates.

Authors:  W P Parks; R S Howk; A Anisowicz; E M Scolnick
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

10.  Sequences from myeloblastosis-associated virus MAV-2(O) and UR2AV involved in the formation of plaques and the induction of osteopetrosis, anemia, and ataxia.

Authors:  R E Aurigemma; J L Torgersen; R E Smith
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.